The Abu Dhabi Biobank is strategically positioned to deliver biobanking excellence across the region, by capitalizing on a wealth of biological and medical data that will serve as a catalyst for scientific breakthroughs, expediting drug discovery, thus contributing to solutions for local and global health challenges. It will significantly impact clinical care and patient outcomes, with emphasis advanced health therapies, personalized treatment and a preventive model of care.
The Abu Dhabi Biobank’s ability to link cord blood, tissue, stem cells, and a wide range of normal and pathological human specimens with established large genomic, proteomics and clinical records, sets the scene for transformative and cutting-edge initiatives.
An important advancement for the nation's health ecosystem, the cord blood bank of Abu Dhabi Biobank will enable better care outcomes, build the nation’s self-sufficiency in meeting the urgent need for cord blood stem cells, and further enhance regional capabilities in research and innovation.
The Pan-human Biobank will collect a variety of biological samples from people, including whole blood, serum, plasma, stool, urine, and saliva, that are connected to anonymized healthcare data, creating a valuable resource for researchers worldwide. By providing access to this information, we’re enhancing our understanding of human health and facilitating promising advancements in life sciences.
We invite collaborations with strategic partners in global healthcare ecosystem to spearhead transformative, unparalleled, science led innovations that shape the healthcare trajectory